J Korean Med Sci.  2011 Jun;26(6):848-849. 10.3346/jkms.2011.26.6.848.

Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis

• Marcuzzi A
• Zanin V
• Vuch J
• Pontillo A
• Crovella S

• KMID: 1785977
• DOI: http://doi.org/10.3346/jkms.2011.26.6.848

Abstract

No abstract available.

MeSH Terms

Anti-Inflammatory Agents/*administration & dosage
Cytokines/blood
Diphosphonates/*administration & dosage
Humans
Injections, Intravenous
Osteoporosis/*drug therapy

Reference

1. Lim MJ, Kwon SR, Park SG, Park W. Acute effects of intravenous administration of pamidronate in patients with osteoporosis. J Korean Med Sci. 2010. 25:1277–1283.

2. Marcuzzi A, Crovella S, Pontillo A. Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In vivo. 2011. 25:87–92.

3. Slobodin G, Rosner I, Feld J, Rimar D, Rozenbaum M, Boulman N, Odeh M. Pamidronate treatment in rheumatology practice: a comprehensive review. Clin Rheumatol. 2009. 28:1359–1364.

4. Cecchini MG, Fleisch H. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. J Bone Miner Res. 1990. 5:1019–1027.

5. Pennanen N, Lapinjoki S, Urtti A, Monkkonen J. Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro. Pharm Res. 1995. 12:916–922.

6. Mandey SH, Kuijk LM, Frenkel J, Waterham HR. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 2006. 54:3690–3695.

7. Thiebaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int. 1997. 61:386–392.

8. Van Offel JF, Schuerwegh AJ, Bridts CH, Bracke PG, Stevens WJ, De Clerck LS. Influence of cyclic intravenous pamidornate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate. Clin Exp Rheumatol. 2001. 19:13–20.

9. Carbone LD, Warrington KJ, Barrow KD, Pugazhenthi M, Watsky MA, Somes G, Ingels J, Postlethwaite AE. Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles. Clin Exp Immunol. 2006. 146:371–380.